Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-548 ax (MIR548AX) is a primate-specific non-coding small RNA molecule classified as a microRNA, and is involved in post-transcriptional regulation of gene expression[3]. Like other microRNAs, it operates by binding to messenger RNAs (mRNAs) to influence their stability or translation, thereby modulating gene expression. While several miR-548 family members have been studied in the context of cancer for roles in cell proliferation, apoptosis, migration, and invasion, there are currently no published data describing specific biological functions, disease associations, or drug interactions for MIR548AX itself[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-548 ax (MIR548AX).